Analysis and Evaluation of Smoking Treatment With Cytisine

Launched by REGINA ELENA CANCER INSTITUTE · May 27, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a medication called Cytisine to help people stop smoking. Researchers want to find out if Cytisine is an effective treatment for those struggling with moderate to severe tobacco use disorder. The goal is to offer a new option for quitting smoking, especially since there aren’t many studies on this treatment and smoking can lead to serious health issues.

To participate in the trial, you need to be at least 18 years old and have a moderate to severe addiction to tobacco. You will also need to be prescribed Cytisine as part of your treatment. If you join the study, you can expect regular check-ups to monitor your progress. It’s important to note that certain individuals, such as pregnant or breastfeeding women, or those with specific health conditions, cannot participate. Overall, this trial aims to explore a potentially cost-effective way to help people quit smoking and improve their health.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • patients aged \> 18 years;
• • patients suffering from moderate or severe tobacco use disorder;
• • prescription of pharmacological therapy with Cytisine;
• • patients returned to the 1st check-up on schedule;
• Exclusion Criteria:
• • Patients with contraindications to taking Cytisine and partial receptor agonists nicotinic cholinergics;
• • Patients undergoing pharmacological or physical treatment for neoplastic pathology;
• • Pregnant or breastfeeding women;
• • Patients for whom specific information for objective assessments is not available;